CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy · Terms of Service · Privacy FAQ

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
ASP Isotopes
ASP Isotopes

ASP Isotopes

ASP Isotopes enriches stable isotopes for medical, semiconductor, and nuclear energy customers with Aerodynamic Separation Process and Quantum Enrichment technologies.

Operating headquarters
Dallas, TX, US🇺🇸
Founded
2021
Overview
Relationships
Analysis
Compare
Employees
News
Library

ASP Isotopes Inc. is a NASDAQ-listed (ASPI) advanced materials company that enriches stable isotopes using two proprietary technologies, the Aerodynamic Separation Process and Quantum Enrichment. It operates enrichment facilities in Pretoria, South Africa, supplying isotopes including Carbon-14, Molybdenum-100, Zinc-68, Nickel-64, Ytterbium-176, highly enriched Silicon-28, and depleted Germanium-73 to nuclear medicine and semiconductor customers, and holds a 51% majority stake in South African radiopharmaceutical operator PET Labs.

Through its subsidiary Quantum Leap Energy, the company is developing enriched nuclear fuels such as HALEU, LEU+, and enriched lithium for next-generation reactors, and it completed the acquisition of South African helium and LNG producer Renergen Limited, whose Virginia Gas Project joins the group portfolio. The company is headquartered in Dallas, Texas.

ASP Isotopes - Products & Services

  • Medical Isotopes logo

    Medical Isotopes

    Medical Isotopes is ASP Isotopes' enriched isotope line for nuclear medicine, supplying Molybdenum-100, Ytterbium-176, Zinc-68, Nickel-64, and Carbon-14 precursors.

    Competing Products

    Actinide logo

ASP Isotopes - Similar Companies

Quantum Leap Energy logo

Quantum Leap Energy

Actinide logo

Actinide

actinideinc.com

Hexium logo

Hexium

hexium.com

Precision Periodic logo

Precision Periodic

Arizona Isotope Science Research logo

Arizona Isotope Science Research

azisotopes.org

Molten Salt Solutions logo

Molten Salt Solutions

Nu Planet Pharmaceutical Radioisotopes logo

Nu Planet Pharmaceutical Radioisotopes

nuplanet.tech

Antares logo

Antares

Alpha Source logo

Alpha Source

alphasource.com

LIS Technologies logo

LIS Technologies

laseristech.com

Metatomic Energy logo

Metatomic Energy

Northwest Medical Isotopes logo

Northwest Medical Isotopes

Apollo Atomics logo

Apollo Atomics

apolloatomics.com

NorthStar Medical Radioisotopes logo

NorthStar Medical Radioisotopes

Applied Isotope Technologies logo

Applied Isotope Technologies

sidms.com

ASP Isotopes - Quick Facts

Who are ASP Isotopes' competitors?

Companies similar to ASP Isotopes include Actinide, Quantum Leap Energy, Hexium and Precision Periodic.

When was ASP Isotopes founded?

ASP Isotopes was founded in 2021.

Where is ASP Isotopes' headquarters located?

ASP Isotopes' headquarters is located in Dallas, TX, US.

ASP Isotopes - Classification

Industry
  • Advanced Materials
  • Chemical Companies
  • Nuclear Energy Companies